157 related articles for article (PubMed ID: 1700970)
1. Immunohistochemical comparison of new monoclonal antibody 1C5 and carcinoembryonic antigen in the differential diagnosis of adenocarcinoma of the uterine cervix.
Kudo R; Sasano H; Koizumi M; Orenstein JM; Silverberg SG
Int J Gynecol Pathol; 1990; 9(4):325-36. PubMed ID: 1700970
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical studies on carcinoembryonic antigen in adenocarcinomas of the uterus.
Ueda S; Tsubura A; Izumi H; Sasaki M; Morii S
Acta Pathol Jpn; 1983 Jan; 33(1):59-69. PubMed ID: 6340419
[TBL] [Abstract][Full Text] [Related]
3. A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin, and estrogen receptor, aids the distinction between primary endometrial and endocervical adenocarcinomas.
McCluggage WG; Sumathi VP; McBride HA; Patterson A
Int J Gynecol Pathol; 2002 Jan; 21(1):11-5. PubMed ID: 11781517
[TBL] [Abstract][Full Text] [Related]
4. Distinction between endocervical and endometrial adenocarcinoma with immunoperoxidase staining of carcinoembryonic antigen in routine histological tissue specimens.
Wahlström T; Lindgren J; Korhonen M; Seppälä M
Lancet; 1979 Dec; 2(8153):1159-60. PubMed ID: 91890
[TBL] [Abstract][Full Text] [Related]
5. [The production and characterization of monoclonal antibody, 1C5, reactive with cervical adenocarcinoma of the uterus].
Koizumi M; Uede T; Kudo R
Nihon Sanka Fujinka Gakkai Zasshi; 1989 May; 41(5):530-6. PubMed ID: 2474040
[TBL] [Abstract][Full Text] [Related]
6. New monoclonal antibody, 1C5, reactive with human cervical adenocarcinoma of the uterus, with immunodiagnostic potential.
Koizumi M; Uede T; Shijubo N; Kudo R; Hashimoto M; Kikuchi K
Cancer Res; 1988 Nov; 48(22):6565-72. PubMed ID: 3052807
[TBL] [Abstract][Full Text] [Related]
7. Localization of carcinoembryonic antigen in uterine cervical neoplasia.
Agarwal S; Sharma S
Indian J Med Res; 1990 Dec; 92():452-5. PubMed ID: 2079363
[TBL] [Abstract][Full Text] [Related]
8. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
McCluggage WG; Shah R; Connolly LE; McBride HA
Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
[TBL] [Abstract][Full Text] [Related]
9. The distribution of mucins, carcinoembryonic antigen, and mucus-associated antigens in endocervical and endometrial adenocarcinomas.
Maes G; Fleuren GJ; Bara J; Nap M
Int J Gynecol Pathol; 1988; 7(2):112-22. PubMed ID: 3294194
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical localizations of CA 125, carcinoembryonic antigen, and CA 19-9 in normal and neoplastic glandular cells of the uterine cervix.
Nanbu Y; Fujii S; Konishi I; Nonogaki H; Mori T
Cancer; 1988 Dec; 62(12):2580-8. PubMed ID: 3191457
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix.
Cina SJ; Richardson MS; Austin RM; Kurman RJ
Mod Pathol; 1997 Mar; 10(3):176-80. PubMed ID: 9071723
[TBL] [Abstract][Full Text] [Related]
12. Tissue-based Immunohistochemical Biomarker Accuracy in the Diagnosis of Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review of the Literature and Meta-Analysis.
Lee S; Rose MS; Sahasrabuddhe VV; Zhao R; Duggan MA
Int J Gynecol Pathol; 2017 Jul; 36(4):310-322. PubMed ID: 27801764
[TBL] [Abstract][Full Text] [Related]
13. p16 INK4 and CEA can be mutually exchanged with confidence between both relevant three-marker panels (ER/Vim/CEA and ER/Vim/p16 INK4) in distinguishing primary endometrial adenocarcinomas from endocervical adenocarcinomas in a tissue microarray study.
Han CP; Lee MY; Tyan YS; Kok LF; Yao CC; Wang PH; Hsu JD; Tseng SW
Virchows Arch; 2009 Oct; 455(4):353-61. PubMed ID: 19763614
[TBL] [Abstract][Full Text] [Related]
14. The immunohistochemical discrimination of endometrioid adenocarcinomas.
Dabbs DJ; Sturtz K; Zaino RJ
Hum Pathol; 1996 Feb; 27(2):172-7. PubMed ID: 8617459
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical localization of carcinoembryonic antigen in microglandular hyperplasia and adenocarcinoma of the endocervix.
Speers WC; Picaso LG; Silverberg SG
Am J Clin Pathol; 1983 Jan; 79(1):105-7. PubMed ID: 6336881
[TBL] [Abstract][Full Text] [Related]
16. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
[TBL] [Abstract][Full Text] [Related]
17. Distinction between endometrial and endocervical adenocarcinoma: an immunohistochemical study.
Castrillon DH; Lee KR; Nucci MR
Int J Gynecol Pathol; 2002 Jan; 21(1):4-10. PubMed ID: 11781516
[TBL] [Abstract][Full Text] [Related]
18. Minimal deviation endocervical adenocarcinoma: clinical and histologic features, immunohistochemical staining for carcinoembryonic antigen, and differentiation from confusing benign lesions.
Michael H; Grawe L; Kraus FT
Int J Gynecol Pathol; 1984; 3(3):261-76. PubMed ID: 6500801
[TBL] [Abstract][Full Text] [Related]
19. [Immunohistochemical study of carcinoembryonic antigen of the tissue and cell levels in adenocarcinoma of the uterus].
Suzuki M; Ohwada M; Tamada T; Shiina Y
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jun; 37(6):897-902. PubMed ID: 3894535
[TBL] [Abstract][Full Text] [Related]
20. Intermediate filaments in endometrial and endocervical carcinomas. The diagnostic utility of vimentin patterns.
Dabbs DJ; Geisinger KR; Norris HT
Am J Surg Pathol; 1986 Aug; 10(8):568-76. PubMed ID: 2426982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
